Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pathology & Oncology Research
Published in: Pathology & Oncology Research 2/2003

01-06-2003 | Article

Overexpression of ROCK in human breast cancer cells: Evidence that ROCK activity mediates intracellular membrane traffic of lysosomes

Authors: Yukio Nishimura, Kazuyuki Itoh, Kiyoko Yoshioka, Kazuo Tokuda, Masaru Himeno

Published in: Pathology & Oncology Research | Issue 2/2003

Login to get access
Metadata
Title
Overexpression of ROCK in human breast cancer cells: Evidence that ROCK activity mediates intracellular membrane traffic of lysosomes
Authors
Yukio Nishimura
Kazuyuki Itoh
Kiyoko Yoshioka
Kazuo Tokuda
Masaru Himeno
Publication date
01-06-2003
Publisher
Springer Netherlands
Published in
Pathology & Oncology Research / Issue 2/2003
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI
https://doi.org/10.1007/BF03033750

Other articles of this Issue 2/2003

Pathology & Oncology Research 2/2003 Go to the issue

Article

Cancer epidemiology in Hungary and the Béla Johan national program for the decade of health

Article

Is Nothingham Prognostic Index correlated with apoptosis and P53 expression in infiltrating ductal carcinoma of the breast?

Article

Genotypic analysis in primary systemic anaplastic large cell lymphoma

Case Report

Salvage chemotherapy with donor lymphocyte infusion and STI 571 in a patient relapsing with B-lymphoblastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation

Case Report

Rare sellar region tumors

Article

High risk HPV types in southern Iranian patients with cervical cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits